Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317888716> ?p ?o ?g. }
- W4317888716 endingPage "1968" @default.
- W4317888716 startingPage "1959" @default.
- W4317888716 abstract "With the advent of efficacious oral direct-acting antivirals (DAAs) for hepatitis C virus (HCV), identification of characteristics associated with adherence is critical to treatment success. We examined correlates of sub-optimal adherence to HCV therapy in a single-arm, multinational, clinical trial.ACTG A5360 enrolled HCV treatment-naive persons without decompensated cirrhosis from 5 countries. All participants received a 12-weeks course of sofosbuvir/velpatasvir at entry. In-person visits occurred at initiation and week 24, sustained virologic response (SVR) assessment. Adherence at week 4 was collected remotely and was dichotomized optimal (100%, no missed doses) versus sub-optimal (<100%). Correlates of sub-optimal adherence were explored using logistic regression.In total, 400 participants enrolled; 399 initiated treatment; 395/397 (99%) reported completing at week 24. Median age was 47 years with 35% female. Among the 368 reporting optimal adherence at week 4 SVR was 96.5% (95% confidence interval [CI] [94.1%, 97.9%]) vs 77.8% (95% CI [59.2%, 89.4%]) P value < .001. In the multivariate model age <30 years and being a US participant were independently associated with early sub-optimal adherence. Participants <30 years were 7.1 times more likely to have early sub-optimal adherence compared to their older counterparts.Self-reported optimal adherence at week 4 was associated with SVR. Early self-reported adherence could be used to identify those at higher risk of treatment failure and may benefit from additional support. Younger individuals <30 years may also be prioritized for additional adherence support. Clinical Trials Registration. NCT03512210." @default.
- W4317888716 created "2023-01-25" @default.
- W4317888716 creator A5002716695 @default.
- W4317888716 creator A5010195988 @default.
- W4317888716 creator A5045447716 @default.
- W4317888716 creator A5054201295 @default.
- W4317888716 creator A5054840982 @default.
- W4317888716 creator A5055149491 @default.
- W4317888716 creator A5072763855 @default.
- W4317888716 creator A5075955805 @default.
- W4317888716 creator A5080496049 @default.
- W4317888716 creator A5089959397 @default.
- W4317888716 date "2023-01-24" @default.
- W4317888716 modified "2023-10-14" @default.
- W4317888716 title "Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment" @default.
- W4317888716 cites W2049863380 @default.
- W4317888716 cites W2304392184 @default.
- W4317888716 cites W2514263904 @default.
- W4317888716 cites W2583841702 @default.
- W4317888716 cites W2756861249 @default.
- W4317888716 cites W2760114581 @default.
- W4317888716 cites W2782256918 @default.
- W4317888716 cites W2790029625 @default.
- W4317888716 cites W2791786965 @default.
- W4317888716 cites W2890228622 @default.
- W4317888716 cites W2895815892 @default.
- W4317888716 cites W2940827946 @default.
- W4317888716 cites W2947594885 @default.
- W4317888716 cites W2954829455 @default.
- W4317888716 cites W2978744917 @default.
- W4317888716 cites W2983079771 @default.
- W4317888716 cites W2985214709 @default.
- W4317888716 cites W3012688111 @default.
- W4317888716 cites W3015099862 @default.
- W4317888716 cites W3080135055 @default.
- W4317888716 cites W3081798049 @default.
- W4317888716 cites W3111596700 @default.
- W4317888716 cites W3130311664 @default.
- W4317888716 cites W3177179925 @default.
- W4317888716 cites W3207125534 @default.
- W4317888716 cites W4205638443 @default.
- W4317888716 cites W4240884543 @default.
- W4317888716 doi "https://doi.org/10.1093/cid/ciad034" @default.
- W4317888716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36694361" @default.
- W4317888716 hasPublicationYear "2023" @default.
- W4317888716 type Work @default.
- W4317888716 citedByCount "0" @default.
- W4317888716 crossrefType "journal-article" @default.
- W4317888716 hasAuthorship W4317888716A5002716695 @default.
- W4317888716 hasAuthorship W4317888716A5010195988 @default.
- W4317888716 hasAuthorship W4317888716A5045447716 @default.
- W4317888716 hasAuthorship W4317888716A5054201295 @default.
- W4317888716 hasAuthorship W4317888716A5054840982 @default.
- W4317888716 hasAuthorship W4317888716A5055149491 @default.
- W4317888716 hasAuthorship W4317888716A5072763855 @default.
- W4317888716 hasAuthorship W4317888716A5075955805 @default.
- W4317888716 hasAuthorship W4317888716A5080496049 @default.
- W4317888716 hasAuthorship W4317888716A5089959397 @default.
- W4317888716 hasBestOaLocation W43178887161 @default.
- W4317888716 hasConcept C126322002 @default.
- W4317888716 hasConcept C151956035 @default.
- W4317888716 hasConcept C168563851 @default.
- W4317888716 hasConcept C203014093 @default.
- W4317888716 hasConcept C2522874641 @default.
- W4317888716 hasConcept C2776408679 @default.
- W4317888716 hasConcept C2776455275 @default.
- W4317888716 hasConcept C2777214474 @default.
- W4317888716 hasConcept C2778390639 @default.
- W4317888716 hasConcept C2780040827 @default.
- W4317888716 hasConcept C44249647 @default.
- W4317888716 hasConcept C535046627 @default.
- W4317888716 hasConcept C71924100 @default.
- W4317888716 hasConceptScore W4317888716C126322002 @default.
- W4317888716 hasConceptScore W4317888716C151956035 @default.
- W4317888716 hasConceptScore W4317888716C168563851 @default.
- W4317888716 hasConceptScore W4317888716C203014093 @default.
- W4317888716 hasConceptScore W4317888716C2522874641 @default.
- W4317888716 hasConceptScore W4317888716C2776408679 @default.
- W4317888716 hasConceptScore W4317888716C2776455275 @default.
- W4317888716 hasConceptScore W4317888716C2777214474 @default.
- W4317888716 hasConceptScore W4317888716C2778390639 @default.
- W4317888716 hasConceptScore W4317888716C2780040827 @default.
- W4317888716 hasConceptScore W4317888716C44249647 @default.
- W4317888716 hasConceptScore W4317888716C535046627 @default.
- W4317888716 hasConceptScore W4317888716C71924100 @default.
- W4317888716 hasFunder F4320332161 @default.
- W4317888716 hasFunder F4320337347 @default.
- W4317888716 hasIssue "11" @default.
- W4317888716 hasLocation W43178887161 @default.
- W4317888716 hasLocation W43178887162 @default.
- W4317888716 hasLocation W43178887163 @default.
- W4317888716 hasOpenAccess W4317888716 @default.
- W4317888716 hasPrimaryLocation W43178887161 @default.
- W4317888716 hasRelatedWork W2319637145 @default.
- W4317888716 hasRelatedWork W2322431879 @default.
- W4317888716 hasRelatedWork W2338920708 @default.
- W4317888716 hasRelatedWork W2521375301 @default.
- W4317888716 hasRelatedWork W2603358003 @default.